HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 168 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $209 | +74.2% | 5,485 | +64.3% | 0.00% | – |
Q2 2023 | $120 | -99.9% | 3,339 | -12.8% | 0.00% | – |
Q3 2022 | $151,000 | – | 3,831 | -65.7% | 0.00% | – |
Q1 2021 | $0 | -100.0% | 11,159 | +1323.3% | 0.00% | – |
Q4 2020 | $33,000 | -96.2% | 784 | -97.6% | 0.00% | -100.0% |
Q3 2020 | $870,000 | +383.3% | 33,127 | +230.2% | 0.00% | – |
Q1 2020 | $180,000 | +16.1% | 10,032 | +10.6% | 0.00% | – |
Q2 2019 | $155,000 | +1.3% | 9,071 | -5.1% | 0.00% | – |
Q1 2019 | $153,000 | +11.7% | 9,562 | +1.7% | 0.00% | – |
Q4 2018 | $137,000 | -42.4% | 9,406 | -28.4% | 0.00% | -100.0% |
Q3 2018 | $238,000 | +83.1% | 13,135 | +70.2% | 0.00% | 0.0% |
Q2 2018 | $130,000 | +5.7% | 7,717 | +22.0% | 0.00% | -80.0% |
Q1 2018 | $123,000 | -45.1% | 6,325 | -42.9% | 0.01% | -50.0% |
Q4 2017 | $224,000 | +194.7% | 11,077 | +151.5% | 0.01% | +233.3% |
Q3 2017 | $76,000 | +300.0% | 4,404 | +193.6% | 0.00% | +200.0% |
Q1 2017 | $19,000 | +375.0% | 1,500 | +385.4% | 0.00% | – |
Q3 2015 | $4,000 | -98.7% | 309 | -97.8% | 0.00% | -100.0% |
Q2 2015 | $314,000 | +613.6% | 13,933 | +350.6% | 0.03% | +420.0% |
Q1 2015 | $44,000 | – | 3,092 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 19,816,162 | $191,226,000 | 8.73% |
BB BIOTECH AG | 6,825,532 | $65,866,000 | 2.13% |
Lombard Odier Asset Management (USA) Corp | 2,700,000 | $26,055,000 | 1.79% |
SECTORAL ASSET MANAGEMENT INC | 3,724,351 | $35,940,000 | 1.61% |
QVT Financial LP | 2,010,186 | $19,398,000 | 0.97% |
JHL Capital Group LLC | 1,475,000 | $14,234,000 | 0.94% |
MAZAMA CAPITAL MANAGEMENT INC | 358,087 | $3,456,000 | 0.79% |
EcoR1 Capital, LLC | 160,700 | $1,551,000 | 0.78% |
Alden Global Capital Ltd | 332,500 | $3,209,000 | 0.77% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 7,274,065 | $70,195,000 | 0.65% |